Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gross

Showing results (661-670 of 685) with videos related to

Pageof 69
Sort By:
Brain : a Journal of Neurology|April 13, 2021
Classification of neurological diseases using multi-dimensional CSF analysisCatharina C Gross, Andreas Schulte-Mecklenbeck, Lohith Madireddy, et al.
Brain : a Journal of Neurology|December 1, 2021
Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunityMarie Liebmann, Lisanne Korn, Claudia Janoschka, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease reboundClaudia Janoschka, Maren Lindner, Nils Koppers, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 14, 2016
Neurochondrin is a neuronal target antigen in autoimmune cerebellar degenerationRamona Miske, Catharina C Gross, Madeleine Scharf, et al.
Therapeutic Advances in Neurological Disorders|December 12, 2023
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment responseValerie E Teschner, Ann-Katrin Fleck, Carolin Walter, et al.
Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
The Journal of Experimental Medicine|October 28, 2022
Correction: Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosisTilman Schneider-Hohendorf, Lisa Ann Gerdes, Béatrice Pignolet, et al.
The Journal of Experimental Medicine|September 1, 2022
Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosisTilman Schneider-Hohendorf, Lisa Ann Gerdes, Béatrice Pignolet, et al.
Brain : a Journal of Neurology|March 17, 2025
Activated αβ T- and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitisDaniela Esser, Louisa Müller-Miny, Michael Heming, et al.
Neurological Research and Practice|December 16, 2020
S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version)H Tumani, H F Petereit, A Gerritzen, et al.
Pageof 69

Showing results (661-670 of 685) with videos related to

Sort By:
Pageof 69
Brain : a Journal of Neurology|April 13, 2021
Classification of neurological diseases using multi-dimensional CSF analysisCatharina C Gross, Andreas Schulte-Mecklenbeck, Lohith Madireddy, et al.
Brain : a Journal of Neurology|December 1, 2021
Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunityMarie Liebmann, Lisanne Korn, Claudia Janoschka, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease reboundClaudia Janoschka, Maren Lindner, Nils Koppers, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 14, 2016
Neurochondrin is a neuronal target antigen in autoimmune cerebellar degenerationRamona Miske, Catharina C Gross, Madeleine Scharf, et al.
Therapeutic Advances in Neurological Disorders|December 12, 2023
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment responseValerie E Teschner, Ann-Katrin Fleck, Carolin Walter, et al.
Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
The Journal of Experimental Medicine|October 28, 2022
Correction: Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosisTilman Schneider-Hohendorf, Lisa Ann Gerdes, Béatrice Pignolet, et al.
The Journal of Experimental Medicine|September 1, 2022
Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosisTilman Schneider-Hohendorf, Lisa Ann Gerdes, Béatrice Pignolet, et al.
Brain : a Journal of Neurology|March 17, 2025
Activated αβ T- and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitisDaniela Esser, Louisa Müller-Miny, Michael Heming, et al.
Neurological Research and Practice|December 16, 2020
S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version)H Tumani, H F Petereit, A Gerritzen, et al.
Pageof 69